Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2002
12/27/2002WO2002103333A1 Method of high throughput haze screening of material
12/27/2002WO2002103324A2 Method and device for withdrawing a sample from a fluid batch
12/27/2002WO2002103321A2 Methods of screening for ligands of target molecules
12/27/2002WO2002103320A2 Diagnosis and prognosis of breast cancer patients
12/27/2002WO2002103059A2 Innate immunity markers for rapid diagnosis of infectious diseases
12/27/2002WO2002103052A1 Amplifiable probe
12/27/2002WO2002103051A2 Nucleic acid triplex and quadruplex formation
12/27/2002WO2002103050A2 Virus detection method, primers therefor and screening kit
12/27/2002WO2002103047A2 Genomic mapping method
12/27/2002WO2002103042A2 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002WO2002103039A1 A method for measuring dna polymerization and applications of the method
12/27/2002WO2002103037A1 Conductometric detection process
12/27/2002WO2002103035A1 Improved method for assessing liver disease
12/27/2002WO2002103034A1 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
12/27/2002WO2002103033A1 Method of detecting and separating undifferentiated liver cellss using dlk
12/27/2002WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002WO2002103028A2 In silico screening for phenotype-associated expressed sequences
12/27/2002WO2002103020A1 Novel disease-associated gene and use thereof
12/27/2002WO2002103015A2 Abca10 transporter
12/27/2002WO2002103012A1 Chimaeric phages
12/27/2002WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002WO2002103003A1 Lipid-modified enzymes, process for producing the same and biosensor
12/27/2002WO2002103002A2 Gene associated with leishmania parasite virulence
12/27/2002WO2002103000A2 Methods for modulating gap junctions
12/27/2002WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same
12/27/2002WO2002102988A2 Method for neural stem cell differentiation using 5ht-1a agonists
12/27/2002WO2002102987A2 Methods and compositions based on protein interactions with mastermind
12/27/2002WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002WO2002102977A2 Characterization of a membrane estrogen receptor
12/27/2002WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102855A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
12/27/2002WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102847A1 Novel ligand and dna thereof
12/27/2002WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002WO2002102842A1 Immunogenic helicobacter surface proteins and their use
12/27/2002WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof
12/27/2002WO2002102836A2 Moraxella (branhamella) catarrhalis antigens
12/27/2002WO2002102834A2 Synthetic sensor peptide for the detection and/or measurement of kinase or phosphate activity of proteins
12/27/2002WO2002102829A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
12/27/2002WO2002102824A2 Method for specific fast detection of relevant bacteria in drinking water
12/27/2002WO2002102693A1 Method for determination of roll density
12/27/2002WO2002102523A1 Method and apparatus for solid state molecular analysis
12/27/2002WO2002102514A1 Microvolume liquid dispenser suitable for microarrays and methods related thereto
12/27/2002WO2002102412A2 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
12/27/2002WO2002102402A1 Anticancer agents
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102249A1 Non-invasive transudate extraction
12/27/2002WO2002102244A1 Compact diagnostic testing device
12/27/2002WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002WO2002102232A2 A novel signaling pathway for the production of inflammatory pain and neuropathy
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002102144A1 Cell deah-inducible model nonhuman animal
12/27/2002WO2002102143A1 Transgenic animal transformed using green fluorescent protein gene
12/27/2002WO2002095036A3 A novel intein and uses thereof
12/27/2002WO2002092199A8 Detection of cells using molecular electrophoretic change
12/27/2002WO2002088746A3 Biopolymer marker having a molecular weight of 1949 daltons
12/27/2002WO2002088745A3 Biopolymer marker having a molecular weight of 2267 daltons
12/27/2002WO2002088742A3 Biopolymer marker having a molecular weight of 2937 daltons
12/27/2002WO2002088730A3 Biopolymer marker having a molecular weight of 1525 daltons
12/27/2002WO2002088729A3 Biopolymer marker having a molecular weight of 1562 daltons
12/27/2002WO2002088728A3 Biopolymer marker having a molecular weight of 1020 daltons
12/27/2002WO2002088726A3 Biopolymer marker having a molecular weight of 1449 daltons
12/27/2002WO2002088722A3 Biopolymer marker having a molecular weight of 1350 daltons
12/27/2002WO2002088721A3 Biopolymer marker having a molecular weight of 1206 daltons
12/27/2002WO2002088719A3 Biopolymer marker having a molecular weight of 1424 daltons
12/27/2002WO2002088718A3 Biopolymer marker having a molecular weight of 1536 daltons
12/27/2002WO2002088713A3 Biopolymer marker having a molecular weight of 1521 daltons
12/27/2002WO2002088710A3 Biopolymer marker having a molecular weight of 2753 daltons
12/27/2002WO2002088663A3 Hand-held automatic refractometer
12/27/2002WO2002088189A3 Polysaccharide derivatives that can be photo-activated for immobilising bio-molecules
12/27/2002WO2002083918A3 Novel microarrays and methods of use thereof
12/27/2002WO2002078848A3 Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
12/27/2002WO2002070662A3 Three hybrid assay system
12/27/2002WO2002070658A9 Compositions and methods for increasing amino acid absorption in mammals
12/27/2002WO2002068120A3 Container for reagents for the analysis by various analytical methods, method for producing a measuring vessel, measuring vessel and use of said measuring vessel
12/27/2002WO2002067766A8 Methods and material for evaluating cardiovascular conditions
12/27/2002WO2002066982A3 Analysis of modification and demodification of proteins with ubiquitin-related proteins by means of fret (fluorescence resonance energy transfer)
12/27/2002WO2002064618A3 Methods of identifying agents that mediate polypeptide aggregation
12/27/2002WO2002057461A3 Regulation of human adam-ts-like zinc metalloprotease
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056888A3 Assay method, tnf modulator and its use
12/27/2002WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease
12/27/2002WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
12/27/2002WO2002046751A9 Methods of predicting chemotherapy response
12/27/2002WO2002044686A3 Predictive method for polymers
12/27/2002WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof
12/27/2002WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
12/27/2002WO2002039118A8 Screening methods for bone morphogenetic mimetics
12/27/2002WO2002038795A3 Braf35 protein and brca2/braf35 complex and methods of use
12/27/2002WO2002037122A3 Sterol glucoside toxins
12/27/2002WO2002027320A3 Method for immobilising lipid layers
12/27/2002WO2002025281A3 Method for validating biochemically coded security documents and documents of value
12/27/2002WO2002019594A3 Scanning fluorescence lifetime microscope: directed evolution
12/27/2002WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002WO2002016593A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/27/2002WO2002014856A3 Mass spectrometry
12/27/2002WO2002012467A3 Drug metabolizing enzymes
1 ... 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 ... 3937